Status:

COMPLETED

MD Logic Pump Advisor- Adults Study

Lead Sponsor:

Rabin Medical Center

Collaborating Sponsors:

Medtronic

Conditions:

Type 1 Diabetes

Insulin Pump Therapy

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Prospective, randomized, controlled, 30-78 days trial comparing MD-Logic pump algorithm to the standard of care of patients with type 1 diabetes. The objective of this feasibility study is to evaluat...

Detailed Description

the MD-Logic Pump Advisor was design by the Diabetes Technology Center, the Institute of Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Isra...

Eligibility Criteria

Inclusion

  • Subject with Type 1 diabetes (\>1yr since diagnosis)
  • Medtronic( MiniMed Paradigm 522, 512 , 722 or 712) insulin infusion pump CSII therapy for at least 3 months
  • Age ≥ 18 years
  • HbA1c at inclusion ≥ 6.0%
  • No concomitant diseases that influence metabolic control
  • No current use of CGM
  • Subjects do not participate in any other interventional study

Exclusion

  • Known or suspected allergy to trial products.
  • Any significant diseases or conditions including psychiatric disorders and substance abuse that, in the opinion of the investigator, is likely to affect the subject's ability to complete the study, or compromise patient safety
  • Subject is currently using CGM device
  • Diabetic ketoacidosis in the past 3 months.
  • Severe hypoglycemia resulting in seizure or loss of consciousness in the month prior to enrollment.
  • Current use of oral glucocorticoids or other medications, which in the judgment of the investigator would be a contraindication to participation in the study.
  • Subject is participating in another drug or device study that could affect glucose measurements or glucose management.
  • Female subject who is pregnant or planning to become pregnant within the planned study duration

Key Trial Info

Start Date :

July 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2016

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT01157923

Start Date

July 1 2010

End Date

July 1 2016

Last Update

January 11 2017

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Schneider Children's Medical center

Petaach-Tikva, Israel, 49202

2

University Children's Hospital

Ljubljana, Slovenia